Hemoglobin-vesicles for a transfusion alternative and targeted oxygen delivery

Journal of Liposome Research

Volumn 17, Issue 3-4, 2007, Pages 227-235

  Sakai, Hiromi ^a   Tsuchida, Eishun ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Blood substitutes; Hemoglobin; Ischemia; Liposome; PEG

Indexed keywords

HEMOGLOBIN; MACROGOL; OXYGEN; PHOSPHATE;

ALLOSTERISM; CONFERENCE PAPER; CONTROLLED STUDY; DEOXYGENATION; DRUG EFFICACY; DRUG SAFETY; ENCAPSULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; ROOM TEMPERATURE;

BLOOD TRANSFUSION; HEMOGLOBINS; HUMANS; ISCHEMIA; MICROSCOPY, ELECTRON, TRANSMISSION; OXYGEN;

EID: 36248968719     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100701529904     Document Type: Conference Paper

References (56)

1. Abe, H., Fujihara, M., Azuma, H., Ikeda, H., Ikebuchi, K., Takeoka, S., Tsuchida, E., Harashima, H. (2006). Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems. Artif. Cell Blood Substit. Biotechnol.. 34:1-10.
2. Abe, H., Ikebuchi, K., Hirayama, J., Fujihara, M., Takeoka, S., Sakai, H., Tsuchida, E., Ikeda H. (2001). Virus inactivation in hemoglobin solution by heat treatment. Artif. Cell Blood Substit. Immobil. Biotechnol. 29:381-388.
3. 2 diffusivity and delivery on glomerular and tubular function in hypoxic perfused kidney. Am J Physiol Renal Physiol. 274:F744-F752.
4. 2 metabolism in proximal tubules. J Appl Physiol. 95:563-570.
5. Bangham, A. D., Horne, R. W. (1964). Negative staining of phospholipids and their structure modification by surface-active agents as observed in the electron microscope. J Mol Biol. 8:660-668.
6. Beissinger, R. L., Farmer, M. C., Gossage, J. L. (1986). Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up. ASAIO Trans 32:58-63.
7. Benesch, R. E., Yung, S., Suzuki, T., Bauer, C., Benesch, R. (1973). Pyridoxal compounds as specific reagents for the alpha and beta N-termini of hemoglobin. Proc. Natl. Acad. Sci. USA 70:2595-2599.
8. Brandl, M., Gregoriadis, G. (1994). Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: Vesicle characterization and in-vivo behavior. Biochim. Biophys. Acta 1196:65-75.
9. Chang, T. M. S. (1984). Artificial cells in medicine and biotechnology. Appl. Biochem. Biotechnol. 10:5-24.
10. Contaldo, C., Plock, J., Sakai, H., Takeoka, S., Tsuchida, E., Leunig, M., Banic, A., Erni, D. (2005). New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit. Care. Med. 33:806-812.
11. Contaldo, C., Schramm, S., Wettstein, R., Sakai, H., Takeoka, S., Tsuchida, E., Leunig, M., Banic, A., Erni, D. (2003). Improved oxygenation in ischemic hamster flap tissue is correlated with increasing hemodilution with Hb vesicles and their O2 affinity. Am. J Physiol. Heart Circ. Physiol. 285:H1140-H1147.
12. Djordjevich, L., Miller, I. F. (1977). Lipid encapsulated hemoglobin as a synthetic erythrocyte. Fed. Proc. 36:567.
13. Erni, D., Sakai, H., Tsai, A. G., Banic, A., Sigurdsson, G. H., Intaglietta, M. (1999). Hemodynamics and oxygen tension in the microcirculation of ischaemic skin flaps after neural blockade and hemodilution. Br. J Plast. Surg. 52:565-572.
14. Erni, D., Wettstein, R., Schramm, S., Contaldo, C., Sakai, H., Takeoka, S., Tsuchida, E., Leunig, M., Banic, A. (2003). Normovolemic hemodilution with Hb vesicle solution attenuates hypoxia in ischemic hamster flap tissue. Am. J Physiol. Heart Circ. Physiol. 284:H1702-H1709.
15. Goda, N., Suzuki, K., Naito, M., Takeoka, S., Tsuchida, E., Ishimura, Y., Tamatani, T., Suematsu, M. (1998). Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin. Invest 101:604-612.
16. Hayward, J. A., Levine, D. M., Neufeld, L., Simon, S. R., Johnston, D. S., Chapman, D. (1985). Polymerized liposomes as stable oxygen-carriers. FEBS Lett 187:261-266.
17. Hunt, C. A., Burnette, R. R. (1983). Neohemocytes. Prog. Clin. Biol. Res. 122:59-69.
18. Izumi, Y., Sakai, H., Takeoka, S., Kose, T., Hamada, K., Yoshizu, A., Horinouchi, H., Kato, R., Nishide, H., Tsuchida, E., Kobayashi, K. (1997). Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model. ASAIO J. 43:289-97.
19. Kato, A., Tanaka, I., Arakawa, M., Kondo, T. (1985). Liposome-type artificial red blood cells stabilized with carboxymethyl chitin. Biomater. Med. Devices Artif. Organs 13:61-82.
20. Kimoto, S., Hori, M., Toyoda, T., Sekiguchi, W. (1968). Artificial red cells. Gekachiryou (Surgical Therapy) 19:324-332 (in Japanese).
21. Li, S., Nickels, J., Palmer, A. F. (2005). Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. Biomaterials 26:3759-3769.
22. Linberg, R., Conover, C. D., Shum, K. L., Shorr, R. G. (1988). Increased tissue oxygenation and enhanced radiation sensitivity of solid tumors in rodents following polyethylene glycol conjugated bovine hemoglobin administration. In Vivo 12:167-173.
23. Liu, L., Yonetani, T. (1994). Preparation and characterization of liposome-encapsulated hemoglobin by a freeze-thaw method. J Microencapsul. 11:409-421.
24. Murray, J. A., Ledlow, A., Launspach, J., Evans, D., Loveday, M., Conklin, J. L. (1995). The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109:1241-1248.
25. Naito, Y., Fukutomi, I., Masada, Y., Sakai, H., Takeoka, S., Tsuchida, E., Abe, H., Hirayama, J., Ikebuchi, K., Ikeda, H. (2002). Virus removal from hemoglobin solution using Planova membrane. J Artif. Organs 5:141-145.
26. Nakai, K., Usuba, A., Ohta, T., Kuwabara, M., Nakazato, Y., Motoki, R., Takahashi, T. A. (1998). Coronary vascular bed perfusion with a polyethylene glycol-modified hemoglobin-encapsulated liposome, neo red cell, in rats. Artif. Organs 22:320-325.
27. Nemoto, M., Mito, T., Brinigar, W. S., Fronticelli, C., Koehler, R. C. (2006). Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse. J Appl. Physiol. 100:1688-91.
28. Phillips, W. T., Klipper, R. W., Awasthi, V. D., Rudolph, A. S., Cliff, R., Kwasiborski, V., Goins, B. A. (1999). Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J Pharmacol. Exp. Ther. 288:665-670.
29. Plock, J. A., Contaldo, C., Sakai, H., Tsuchida, E., Leunig, M., Banic, A., Menger, M. D., Erni, D. (2005). Is hemoglobin in hemoglobin vesicles infused for isovolemic hemodilution necessary to improve oxygenation in critically ischemic hamster skin? Am. J Physiol. Heart Circ. Physiol. 289:H2624-H2631.
30. Plock, J. A., Tromp, A. E., Contaldo, C., Spanholtz, T., Sinovcic, D., Sakai, H., Tsuchida, E., Leunig, M., Banic, A., Erni, D. (2007). Hemoglobin vesicles reduce hypoxia-related inflammation in critically ischemic hamster flap tissue. Crit. Care Med. 35:899-905.
31. 99mTc- labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. USA 88:10976-10980.
32. Sakai, H., Hamada, K., Takeoka, S., Nishide, H., Tsuchida, E. (1996). Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol. Progress 12:119-125.
33. 2 carriers determine constriction of resistance arteries and hypertension. Am. J Physiol. Heart Circ. Physiol. 279:H908-H915.
34. Sakai, H., Horinouchi, H., Masada, Y., Yamamoto, M., Takeoka, S., Kobayashi, K., Tsuchida, E. (2004). Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit. Care Med. 32:539-545.
35. Sakai, H., Horinouchi, H., Yamamoto, M., Ikeda, E., Takeoka, S., Takaori, M., Tsuchida, E., Kobayashi, K. (2006). Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: Degradation of HbV and erythropoiesis in a rat spleen for 2 weeks. Transfusion 46:339-347.
36. Sakai, H., Sato, A., Takeoka, S. Tsuchida, E. (2007). Rheological properties of hemoglobin-vesicles (artificial oxygen carriers) suspended in a series of plasma substitute aqueous solutions. Langmuir 23:8121-8128.
37. 2-permeable tube: Comparison with RBCs and acellular Hbs. Am. J. Physiol. Heart Circ. Physiol. 285:H2543-H2551.
38. Sakai, H., Takeoka, S., Park, S., Kose, T., Izumi, Y., Yoshizu, A., Nishide, H., Kobayashi, K., Tsuchida, E. (1997). Surface-modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90%-exchange transfusion in anesthetized rats. Bioconjugate Chem. 8:23-30.
39. Sakai, H., Takeoka, S., Yokohama, H., Seino, Y., Nishide, H., Tsuchida, E. (1993). Purification of concentrated Hb using organic solvent and heat treatment. Protein Expression Purif. 4:563-569.
40. Sakai, H., Tomiyama, K., Sou, K., Takeoka, S., Tsuchida, E. (2000). Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjugate Chem. 11:425-32.
41. Sakai, H., Tsai, A. G., Kerger, H., Park, S., Takeoka, S., Nishide, H., Tsuchida, E., Intaglietta, M. (1998). Subcutaneous microvascular responses to hemodilution with red cell substitutes consisting of polyethylene glycol-modified vesicles encapsulating hemoglobin. J Biomed. Mater. Res. 40:66-78.
42. 2 consumption, metabolism, and physical activity. J. Biol. Chem. 278:5035-5043.
43. Sou, K., Endo, T., Takeoka, S., Tsuchida, E. (2000). Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjugate Chem. 11:372-379.
44. Sou, K., Klipper, R., Goins, B., Tsuchida, E., Phillips, W. T. (2005). Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J. Pharmacol. Exp. Ther. 312:702-709.
45. Sou, K., Naito, Y., Endo, T., Takeoka, S., Tsuchida, E. (2003). Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol. Progress 19:1547-1552.
46. Stein, J. C., Ellsworth, M. L. (1993). Capillary oxygen transport during severe hypoxia: role of hemoglobin oxygen affinity. J. Appl. Physiol. 75:1601-1607.
47. Takeoka, S., Ohgushi, T., Terase, K., Ohmori, T., Tsuchida, E. (1996). Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 12:1755-1759.
48. Toyoda, T. (1695). Artificial blood. Kagaku 35:7-13 (in Japanese).
49. 2 therapeutics. Am. J. Physiol. Heart Circ. Physiol. 285:H1411-H1419.
50. Usuba, A., Motoki, R., Miyauchi, Y., Suzuki, K., Takahashi, A. (1991). Effect of neo red cells on the canine hemorrhagic shock model. Int. J. Artif. Organs 14:739-744.
51. Wakamoto, S., Fujihara, M., Abe, H., Sakai, H., Takeoka, S., Tsuchida, E., Ikeda, H., Ikebuchi, K. (2001). Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on agonist-induced platelet aggregation and RANTES release in vitro. Artif. Cell Blood Substit. Immobil. Biotechnol. 29:191-201.
52. Wakamoto, S., Fujihara, M., Abe, H., Yamaguchi, M., Azuma, H., Ikeda, H., Takeoka, S., Tsuchida, E. (2005). Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. Artif. Cell Blood Substit. Immobil. Biotechnol. 33:101-111.
53. Wang, L., Morizawa, K., Tokuyama, S., Satoh, T., Tsuchida, E. (1992) Modulation of oxygen-carrying capacity of artificial red cells (ARC). Polymer Adv Technol. 4:8-11.
54. 50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif. Cell Blood Substit. Immobil. Biotechnol. 33:1-12.
55. Yamazaki, M., Aeba, R., Yozu, R., Kobayashi, K. (2006). Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats. Circulation 114(1 Suppl):I220-I225.
56. Yoshioka, H. (1991). Surface modification of hemoglobin-containing liposomes with poly(ethyleneglycol) prevents liposome aggregation in blood plasma. Biomaterials 12:861-864.